Historical record - last NADAC publication: 11/18/2020
Product Information
OXYMORPHONE HCL ER 30 MG TAB is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $11.9082 per EA under NDC 00115131701. Its NADAC has been published 383 times since Nov 28, 2013.
Strength
30 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115131701
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
11/18/2020
Active Ingredients
OXYMORPHONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA079087On Market Since
1/2/2013
Pharmacological Classes
Price Statistics
The NADAC for OXYMORPHONE HCL ER 30 MG TAB has been published 383 times since Nov 28, 2013, and over the history we have for it it has risen 76.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.9082 per EA |
|---|---|
| All-time high | $11.9082 (Mar 24, 2021) |
| All-time low | $5.5361 (Nov 18, 2015) |
| Median price | $6.7434 |
| Average price | $7.7387 |
| Largest weekly change | +30.2% (Mar 23, 2016) |
| Weeks tracked | 383 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXYMORPHONE HCL ER 30 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OXYMORPHONE HCL ER 30 MG TAB, manufactured by Amneal Pharmaceuticals of New York LLC, is $11.9082 per EA (NDC 00115131701), effective Mar 24, 2021.
How has the price of OXYMORPHONE HCL ER 30 MG TAB changed over time?
Over the history we have for it, the NADAC for OXYMORPHONE HCL ER 30 MG TAB has risen 76.1%. It has been tracked across 383 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for OXYMORPHONE HCL ER 30 MG TAB?
Since Nov 28, 2013, the NADAC for OXYMORPHONE HCL ER 30 MG TAB has ranged from a low of $5.5361 (Nov 18, 2015) to a high of $11.9082 (Mar 24, 2021), with a median of $6.7434 per EA.
Are there cheaper alternatives to OXYMORPHONE HCL ER 30 MG TAB?
2 NADAC-published products share the same active ingredient, strength, and dosage form as OXYMORPHONE HCL ER 30 MG TAB, but none are currently priced below it.
Who manufactures OXYMORPHONE HCL ER 30 MG TAB?
OXYMORPHONE HCL ER 30 MG TAB (NDC 00115131701) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification